Korbmacher M, Lie IA, Wesnes K, Westman E, Espeseth T, Andreassen OA, Harbo H, Nygaard GO, Westlye LT, Wergeland S, Myhr KM, Høgestøl EA, Torkildsen Ø (2026)
Regional patterns of grey matter volume decline in relapsing-remitting multiple sclerosis relative to healthy ageing
Neuroimage, 338, 122118 (in press)
DOI 10.1016/j.neuroimage.2026.122118, PubMed 42419658

Helland GB, Enriquez B, Beyer MK, Rise HS, Ihle-Hansen H, Andersson S, Grambaite R, Stangeland H, Vaskinn A, Ihle-Hansen H, Harbo HF, Høgestøl EA, Hagberg G, Aamodt AH (2026)
Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study
J Neurol Sci, 489, 126075 (in press)
DOI 10.1016/j.jns.2026.126075, PubMed 42391747

Stögbauer J, Bewarder M, Groß L, Thurner L, Fassbender K, Urschel R, Høgestøl EA, Nygaard GO, Harbo HF, Stüve O, Pawlitzki M, Meuth SG, Sester M, Groppa S, Fousse M (2026)
Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort
Front Immunol, 17, 1738865
DOI 10.3389/fimmu.2026.1738865, PubMed 42206028